Aortopathy Panel

Cardiology

Aortopathy Panel

Overview

Test Name
Aortopathy Panel
Test Code
CAE1016
Test Category
Gene Panels
Test Subcategory
Cardiology
Disease(s) Targeted
Aortopathy
Who Is The Test For?
Patients with a family history, clinical suspicion, or diagnosis of an aortopathy
Test Approach

Whole exome sequencing (WES) with in silico gene panel analysis.

No. of Genes
41
Panel Content
ABL1, ACTA2, ARIH1, ASPH, BGN, CBS, COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, EFEMP2, ELN, FBLN5, FBN1, FBN2, FKBP14, FOXE3, FLNA, IPO8, LOX, LTBP3, MFAP5, MYH11, MYLK, NOTCH1, PMEPA1, PLOD1, PRKG1, SECISBP2, SKI, SLC2A10, SMAD2, SMAD3, SMAD4, SMAD6, TGFB2, TGFB3, TGFBR1, TGFBR2, THSD4
Mitochondrial Genome Included In The Analysis
No
Deliverables
Turnaround Time

~3-6 weeks*

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Aortopathy

Aortopathies are a group of disorders affecting the aorta, the largest artery in the body that carries blood from the heart to the rest of the body. These conditions can lead to a weakening, dilation (aneurysm), or tearing (dissection) of the aorta, posing serious health risks. They are the 18th most common cause of death, responsible for around 2% of all deaths in the world.

Some patients with an aortopathy may have a gene variant that predisposes to the development of aortic aneurysms which may or may not be part of a syndrome such as Marfan syndrome (FBN1 gene), Loeys-Dietz Syndrome (e.g: TGFBR1, TGFBR2, or SMAD3 genes), Shprintzen-Goldberg syndrome (SKI gene) and Ehlers-Danlos syndromes (e.g. COL1A1, COL5A1, or COL5A2 genes). These syndromes are often inherited in an autosomal dominant manner, which means that each child of an individual with these syndromes has a 50% chance of inheriting the pathogenic variant.

Gene Panel Workflow

Order a test using our clinical portal

Preview Documents

©2023 Genseq All Rights Reserved.

Terms & Conditions
Privacy Policy
Cookie Policy
Cookie Preferences